| IVORY A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY Bristol-Myers Squibb Company
77762649 31 Dec 1969 | on 24 Jun 2009 | Medical and scientific research, namely, conducting clinical trials an... Class 042 Class 042 Computer & Software Services & Scientific Services Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use | | | BYONMET Bristol-Myers Squibb Company
85124057 07 Sep 2010 | on 23 Apr 2012 | pharmaceutical preparations for the treatment of metabolic disorders,p... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations for the treatment of metabolic disorders | | | ORENCIA DIRECTJECT Bristol-Myers Squibb Company
85227651 27 Jan 2011 | on 30 Jan 2012 | A syringe pre-filled with pharmaceutical preparations for treating aut... Class 005 Class 005 Pharmaceutical Products A syringe pre-filled with pharmaceutical preparations for treating auto-immune diseases for human use | | | METDASI Bristol-Myers Squibb Company
77642685 02 Jan 2009 | on 31 Oct 2011 | Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies | | | INGLUZAR Bristol-Myers Squibb Company
77580782 29 Sep 2008 | on 10 Oct 2011 | Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies | | | METONGLY Bristol-Myers Squibb Company
77694457 19 Mar 2009 | on 10 Oct 2011 | Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies | | | ONGLYZIMET Bristol-Myers Squibb Company
77683910 05 Mar 2009 | on 26 Sep 2011 | Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies | | | LYGLAMET Bristol-Myers Squibb Company
77658047 28 Jan 2009 | on 26 Sep 2011 | Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies | | | ONGLAMET Bristol-Myers Squibb Company
77694449 19 Mar 2009 | on 26 Sep 2011 | Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies | | | METMIGO Bristol-Myers Squibb Company
77658043 28 Jan 2009 | on 26 Sep 2011 | Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies | | 
